(-0.59%) 5 293.50 points
(-0.52%) 38 740 points
(-0.63%) 18 821 points
(0.85%) $80.51
(-0.39%) $2.58
(-0.45%) $2 345.80
(0.18%) $32.20
(-0.70%) $1 059.30
(0.10%) $0.922
(0.03%) $10.51
(0.03%) $0.784
(0.85%) $89.32
@ $4.70
発行日: 15 2月 2024 @ 04:13
リターン: -9.15%
前回のシグナル: 2月 14 - 01:04
前回のシグナル:
リターン: 12.71 %
Live Chart Being Loaded With Signals
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States...
Stats | |
---|---|
本日の出来高 | 1.74M |
平均出来高 | 1.22M |
時価総額 | 482.87M |
EPS | $0 ( 2024-05-20 ) |
次の収益日 | ( $-0.190 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.68 |
ATR14 | $0.0100 (0.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-22 | Phoenix Venture Partners Ii Lp | Sell | 3 100 000 | Common Stock |
2024-03-19 | Mcclain Sean | Buy | 1 500 000 | Common Stock |
2024-03-01 | Redmile Group, Llc | Buy | 222 222 | Common Stock |
2023-12-31 | Phoenix Venture Partners Ii Lp | Buy | 0 | |
2024-02-01 | Bedrick Todd | Buy | 20 570 | Common Stock |
INSIDER POWER |
---|
34.13 |
Last 93 transactions |
Buy: 45 039 233 | Sell: 10 230 968 |
ボリューム 相関
Absci Corporation 相関 - 通貨/商品
Absci Corporation 財務諸表
Annual | 2023 |
収益: | $5.72M |
総利益: | $-8.28M (-144.82 %) |
EPS: | $-1.200 |
FY | 2023 |
収益: | $5.72M |
総利益: | $-8.28M (-144.82 %) |
EPS: | $-1.200 |
FY | 2022 |
収益: | $5.75M |
総利益: | $-7.29M (-126.85 %) |
EPS: | $-1.150 |
FY | 2021 |
収益: | $4.78M |
総利益: | $-1.87M (-39.15 %) |
EPS: | $-1.117 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Absci Corporation
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。